Literature DB >> 21982650

Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.

Jonathan P Piccini1, Elizabeth S Fraulo, Jack E Ansell, Gregg C Fonarow, Bernard J Gersh, Alan S Go, Elaine M Hylek, Peter R Kowey, Kenneth W Mahaffey, Laine E Thomas, Melissa H Kong, Renato D Lopes, Roger M Mills, Eric D Peterson.   

Abstract

BACKGROUND: Atrial fibrillation (AF) is the most common sustained cardiac arrhythmia and is associated with an increased risk of stroke, heart failure, and death. Data on contemporary treatment patterns and outcomes associated with AF in clinical practice are limited. METHODS/
DESIGN: The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation is a multicenter, prospective, ambulatory-based registry of incident and prevalent AF. The registry will be a nationwide collaboration of health care providers, including internists, primary care physicians, cardiologists, and electrophysiologists. Initial target enrollment is approximately 10,000 patients to be recruited from approximately 200 US outpatient practices. Enrolled patients will be observed for ≥2 years. A patient-reported outcomes substudy in ≥1,500 patients will provide serial quality-of-life assessments. The goal is to characterize treatment and outcomes of patients with AF, thereby promoting better quality of AF care and improved patient outcomes.
CONCLUSION: The Outcomes Registry for Better Informed Treatment of Atrial Fibrillation will provide insights into "real-world" treatment including rate and rhythm control, stroke prevention, transitions to new therapies, and clinical and patient-centered outcomes among patients with AF in community practice settings (ClinicalTrials.gov NCT01165710).
Copyright © 2011 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21982650     DOI: 10.1016/j.ahj.2011.07.001

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  59 in total

1.  Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Authors:  Benjamin A Steinberg; Sunghee Kim; Laine Thomas; Gregg C Fonarow; Elaine Hylek; Jack Ansell; Alan S Go; Paul Chang; Peter Kowey; Bernard J Gersh; Kenneth W Mahaffey; Daniel E Singer; Jonathan P Piccini; Eric D Peterson
Journal:  Circulation       Date:  2014-03-29       Impact factor: 29.690

2.  Application of net reclassification index to non-nested and point-based risk prediction models: a review.

Authors:  Laine E Thomas; Emily C O'Brien; Jonathan P Piccini; Ralph B D'Agostino; Michael J Pencina
Journal:  Eur Heart J       Date:  2019-06-14       Impact factor: 29.983

3.  Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry.

Authors:  Benjamin A Steinberg; Rosalia G Blanco; Donna Ollis; Sunghee Kim; DaJuanicia N Holmes; Peter R Kowey; Gregg C Fonarow; Jack Ansell; Bernard Gersh; Alan S Go; Elaine Hylek; Kenneth W Mahaffey; Laine Thomas; Paul Chang; Eric D Peterson; Jonathan P Piccini
Journal:  Am Heart J       Date:  2014-04-18       Impact factor: 4.749

Review 4.  Prospective observational studies of the management and outcomes in patients with atrial fibrillation: A systematic review.

Authors:  Ahmad S Hersi; Alawi A Alsheikh-Ali; Mohammad Zubaid; Jassim Al Suwaidi
Journal:  J Saudi Heart Assoc       Date:  2012-08-23

5.  Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).

Authors:  Benjamin A Steinberg; Sunghee Kim; Gregg C Fonarow; Laine Thomas; Jack Ansell; Peter R Kowey; Kenneth W Mahaffey; Bernard J Gersh; Elaine Hylek; Gerald Naccarelli; Alan S Go; James Reiffel; Paul Chang; Eric D Peterson; Jonathan P Piccini
Journal:  Am Heart J       Date:  2014-02-17       Impact factor: 4.749

6.  Underuse of Oral Anticoagulants and Inappropriate Prescription of Antiplatelet Therapy in Older Inpatients with Atrial Fibrillation.

Authors:  Lorette Averlant; Grégoire Ficheur; Laurie Ferret; Stéphane Boulé; François Puisieux; Michel Luyckx; Julien Soula; Alexandre Georges; Régis Beuscart; Emmanuel Chazard; Jean-Baptiste Beuscart
Journal:  Drugs Aging       Date:  2017-09       Impact factor: 3.923

Review 7.  [Electrophysiologic procedure complications in the elderly].

Authors:  Dietrich Pfeiffer; Martin Neef; Daniel Jurisch; Andreas Hagendorff
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2017-02-09

8.  Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.

Authors:  Benjamin A Steinberg; DaJuanicia N Holmes; Karen Pieper; Larry A Allen; Paul S Chan; Michael D Ezekowitz; James V Freeman; Gregg C Fonarow; Bernard J Gersh; Elaine M Hylek; Peter R Kowey; Kenneth W Mahaffey; Gerald Naccarelli; James Reiffel; Daniel E Singer; Eric D Peterson; Jonathan P Piccini
Journal:  Circ Arrhythm Electrophysiol       Date:  2020-04-16

9.  Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation: Findings From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II.

Authors:  Utibe R Essien; DaJuanicia N Holmes; Larry R Jackson; Gregg C Fonarow; Kenneth W Mahaffey; James A Reiffel; Benjamin A Steinberg; Larry A Allen; Paul S Chan; James V Freeman; Rosalia G Blanco; Karen S Pieper; Jonathan P Piccini; Eric D Peterson; Daniel E Singer
Journal:  JAMA Cardiol       Date:  2018-12-01       Impact factor: 14.676

10.  Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.

Authors:  Benjamin A Steinberg; DaJuanicia N Holmes; Michael D Ezekowitz; Gregg C Fonarow; Peter R Kowey; Kenneth W Mahaffey; Gerald Naccarelli; James Reiffel; Paul Chang; Eric D Peterson; Jonathan P Piccini
Journal:  Am Heart J       Date:  2013-02-20       Impact factor: 4.749

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.